Physician profile
Zeba Hashmath
NPI 1700309622
$48,175.07
in general payments reported to CMS, 2019-2025
33 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $457 · 2021: $982 · 2022: $5,882 · 2023: $10K · 2024: $13K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $17K · Food and Beverage: $11K · Travel and Lodging: $11K · Education: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $16,937.50 |
| Food and Beverage | $11,207.27 |
| Travel and Lodging | $11,159.28 |
| Education | $1,090.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19,181.62 | 2021-2025 | Ensite, Assurity, Tacticath |
| Biotronik INC. | $9,528.76 | 2021-2025 | Acticor 7 Vr-T Dx, Plexa Promri, Edora 8 Dr-T |
| Boston Scientific Corporation | $7,918.88 | 2021-2025 | General - Brady, Watchman Access System, Watchman Flx |
| Medtronic, INC. | $6,950.77 | 2022-2025 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Biosense Webster, INC. | $614.10 | 2024-2025 | Carto 3 |
| Cvrx, INC. | $589.39 | 2022-2024 | Barostim Neo System |
| Abiomed | $485.15 | 2022-2025 | Impella |
| Astrazeneca Pharmaceuticals Lp | $429.34 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $420.11 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $383.80 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $360.47 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.61 | 2019-2024 | Jardiance |
| Irhythm Technologies, INC. | $154.45 | 2024 | Zio Xt Patch, Zio Monitor |
| Baxter Healthcare | $149.34 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Alexion Pharmaceuticals, INC. | $114.74 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $99.98 | 2022-2024 | Repatha |
| Pfizer INC. | $75.14 | 2019-2020 | |
| Biogen, INC. | $73.63 | 2021 | |
| Alnylam Pharmaceuticals INC. | $56.48 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $52.84 | 2023 | Optimizer |
| Abbvie INC. | $47.09 | 2019-2021 | |
| Terumo Medical Corporation | $43.00 | 2023 | Optitorque, Angio-Seal, Glidewire |
| Shire North American Group INC | $40.37 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $34.60 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $33.92 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $28.44 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $24.19 | 2019 | |
| Cardiva Medical, INC. | $23.95 | 2023 | Cardiva Vascade 6/7f Vcs |
| Jazz Pharmaceuticals INC. | $21.00 | 2019 | |
| Novo Nordisk INC | $17.56 | 2023 | Ozempic |
| Sanofi-Aventis U.S. LLC | $15.51 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.96 | 2020 | |
| Merck Sharp & Dohme LLC | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zeba Hashmath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.